GPT and metabolic dysfunction-associated steatohepatitis: Decrease serum CHO and ALT levels, hepatic steatosis, inflammation and fibrosis in NASH mice; increase hepatic mitochondrial content and function, hepatic autophagy to enhance b-oxidation of FFAs in NASH mice